FTSE 100 UCITS ETF
FTSE 100 UCITS ETF - (GBP) Accumulating (VUKG)
Acerca de este fondo
Objetivos del fondo
- El Fondo emplea un enfoque de inversión de gestión pasiva (o indexación), mediante la adquisición física de valores, y trata de replicar la rentabilidad del FTSE 100 Index (el «Índice»).
- El Índice está compuesto por acciones de grandes empresas del Reino Unido.
- El Fondo trata de: 1. Replicar la rentabilidad del Índice invirtiendo, mediante la adquisición física, en todos los valores que lo componen en la misma proporción que el Índice. Cuando no sea factible replicar completamente, el Fondo utilizará un proceso de muestreo. 2. Permanecer totalmente invertido excepto en condiciones extraordinarias de mercado, políticas o similares, en las que el Fondo podrá desviarse temporalmente de esta política de inversión para evitar pérdidas.
- El Fondo podrá realizar préstamos garantizados a corto plazo de sus inversiones a determinados terceros elegibles. Se utiliza como un medio de generar ingresos adicionales y compensar los costes del Fondo. Si bien se prevé que el Fondo realice una replicación lo más fiel posible del Índice, por lo general no se ajustará exactamente a la rentabilidad del Índice objetivo, debido a diversos factores, como los gastos que debe pagar el Fondo y las restricciones normativas. En el Folleto se detallan estos factores y el error de seguimiento previsto del Fondo. Puede encontrar información sobre la cartera del Fondo en https://www.ie.vanguard/products. El valor liquidativo indicativo del fondo se calcula cada día de negociación y se publica en Bloomberg o Reuters.
Datos del fondo
Fecha de lanzamiento
14 may 2019
Fecha de listado
16 may 2019
Estructura de inversión
Irish UCITS
Activos de la clase de acciones
Activos totales
Indicador de riesgo
Estrategia
Índice
Clase de activos
Renta variable
Método de inversión
Físico
Símbolo del índice
UKXNUK
Índice de referencia
FTSE 100 Index
Calendario de dividendos
—
Domicilio
Irlanda
Entidad legal
Vanguard Funds PLC
Países registrados
Austria, Bélgica, Bulgaria, Croacia, Chipre, República Checa, Dinamarca, Estonia, Finlandia, Francia, Alemania, Grecia, Hungría, Islandia, Irlanda, Italia, Letonia, Liechtenstein, Lituania, Luxemburgo, Malta, México, Países Bajos, Noruega, Portugal, Rumania, Eslovaquia, Eslovenia, España, Suecia, Suiza y Reino Unido
El valor de las inversiones y los ingresos procedentes de ellas pueden disminuir o aumentar, y los inversores podrían recuperar menos de lo invertido.
Rentabilidad
Riesgo y volatilidad
Datos a 30 sept 2026
Beta
R al cuadrado
Tracking Error
Tracking error a 1 año
Tracking error a 3 años
Tracking error a 5 años
Datos de la cartera
Características
| Fundamentos | Fondo | Índice de referencia | Datos a |
|---|---|---|---|
| Número de acciones | 104 | 100 | 30 sept 2026 |
| Varianza / Variación mediana | 62,2 B | 62,2 B | 30 sept 2026 |
| 15,1 x | 15,1 x | 30 sept 2026 | |
| 2,2 x | 2,2 x | 30 sept 2026 | |
| 11,9 % | 11,9 % | 30 sept 2026 | |
| 9,1 % | 9,1 % | 30 sept 2026 | |
| Tasa de rotación | -22,3 % | — | 30 sept 2026 |
Varianza / Variación
Datos a 30 sept 2026
| País | Región | Fondo | Índice de referencia | Varianza |
|---|---|---|---|---|
| Reino Unido | Europa | 99,82 % | 100,00 % | -0,18 % |
| Guernsey, C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I. | Europa | 0,18 % | — | — |
Top 10 posiciones
Datos a 30 sept 2026
| Nombre de emisor | % de valor de mercado | Sector | Región | Valor de mercado | Acciones |
|---|---|---|---|---|---|
| HSBC Holdings PLC | 10,10289 % | Financials | GB | 660.387.686,40 GBP | 44.096.400 |
| Shell PLC | 8,19586 % | Energy | GB | 535.731.941,31 GBP | 15.008.599 |
| AstraZeneca PLC | 7,24072 % | Health Care | GB | 473.298.093,20 GBP | 3.854.219 |
| Rolls-Royce Holdings PLC | 4,82189 % | Industrials | GB | 315.188.719,78 GBP | 21.564.636 |
| Unilever PLC | 3,76267 % | Consumer Staples | GB | 245.951.700,89 GBP | 5.342.711 |
| BP PLC | 3,38856 % | Energy | GB | 221.497.537,93 GBP | 40.316.261 |
| British American Tobacco PLC | 3,29546 % | Consumer Staples | GB | 215.411.829,34 GBP | 5.217.046 |
| Rio Tinto PLC | 2,88863 % | Basic Materials | GB | 188.818.989,03 GBP | 2.659.797 |
| GSK PLC | 2,87308 % | Health Care | GB | 187.802.240,48 GBP | 10.251.214 |
| Lloyds Banking Group PLC | 2,46082 % | Financials | GB | 160.854.679,18 GBP | 150.472.104 |
Precios y distribución
Precios
Valor neto de activos (GBP)
58,32 GBP
GBPVariación
+0,64 GBP1,11 % Datos a 15 oct 2026
Precio del mercado (EUR)
69,54 €
Variación
+0,45 €0,65 % Datos a 16 oct 2026
Valor de activos neto Máximo de 52 semanas
58,47 GBP
Datos a 16 oct 2026
Precio del mercado máximo de 52 semanas
69,54 €
Datos a 16 oct 2026
Valor de activos neto Mínimo de 52 semanas
48,84 GBP
Datos a 16 oct 2026
Precio del mercado mínimo de 52 semanas
56,35 €
Datos a 16 oct 2026
Valor de activos neto Diferencia de 52 semanas
9,63 GBP
Variación
+16,47 % Datos a 16 oct 2026
Precio del mercado con diferencia de 52 semanas
13,19 €
Variación
+18,97 % Datos a 16 oct 2026
Acciones en circulación
33.315.966
Datos a 30 sept 2026
Precios históricos
-
Fecha de lanzamiento
14 may 2019
Fecha de listado
09 mar 2023
| Fecha | Valor de activos neto (GBP) | Precio del mercado (EUR) |
|---|---|---|
| 16 oct 2026 | — | 69,5400 € |
| 15 oct 2026 | 58,3218 GBP | 69,0900 € |
| 14 oct 2026 | 57,6788 GBP | 68,3700 € |
| 13 oct 2026 | 57,2778 GBP | 67,9000 € |
| 12 oct 2026 | 57,3099 GBP | 67,9700 € |
| 09 oct 2026 | 56,7501 GBP | 67,2300 € |
| 08 oct 2026 | 56,1562 GBP | 66,3300 € |
| 07 oct 2026 | 56,2430 GBP | 66,6000 € |
| 06 oct 2026 | 56,6904 GBP | 67,0100 € |
| 05 oct 2026 | 56,4550 GBP | 66,7000 € |
Historial de distribución
Frecuencia de distribución
—
Rendimiento histórico 31 mar 2026
3,01 %
Todos los dividendos se reinvierten en las acciones de "acumulación".
Información sobre la suscripción
Monedas y tipos de cambio
Divisas cotizadas: EUR, GBP, MXN
Divisa base del fondo:GBP
Mercados : Deutsche Boerse, London Stock Exchange, Bolsa Mexicana De Valores